Medical technology advances drive growth in neuro-rehabilitation markets

The global markets for cerebral palsy treatment and rehabilitation robotics are experiencing significant growth driven by advancements in medical technology and an increasing prevalence of neurological disorders.

The cerebral palsy treatment market is projected to reach USD 4.39 billion by 2031, growing from USD 3.76 billion in 2026. This expansion is supported by improved neonatal screening protocols, such as General Movement Assessment, which allow for earlier diagnosis and intervention during critical periods of neuroplasticity. Advances in telehealth, AI, and robotics are also playing key roles in pediatric neuro-rehabilitation.

Simultaneously, the rehabilitation robotics market is seeing rapid expansion due to the rising incidence of strokes and traumatic brain injuries. The market is expected to grow from USD 1.81 billion in 2025 to USD 2.22 billion in 2026, with a projected value of USD 4.87 billion by 2030. Key technological trends include the adoption of exoskeleton systems, AI-driven personalized therapy, and the integration of digital health platforms to support both hospital-based and home-based recovery.